ZIM Laboratories Limited (ZIMLAB.NS)
- Previous Close
91.07 - Open
92.49 - Bid --
- Ask --
- Day's Range
87.86 - 92.49 - 52 Week Range
79.49 - 128.90 - Volume
44,113 - Avg. Volume
134,495 - Market Cap (intraday)
4.444B - Beta (5Y Monthly) 0.55
- PE Ratio (TTM)
27.96 - EPS (TTM)
3.15 - Earnings Date May 12, 2025 - May 16, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
ZIM Laboratories Limited engages in the development, manufacture, and supply of generic pharmaceutical and nutraceutical products in India and internationally. The company provides its products in pre- formulation intermediates and finished formulations in the oral solid dosage forms, such as pellets, taste-masked powders, granules, tablets, capsules, dry syrup, and oral thin films. It offers therapeutics in the areas of urology, gastroenterology, antibiotics, anti-infectives, cardiovascular, central nervous system, NSAIDs/pain analgesics, and vitamins and supplements. The company was incorporated in 1984 and is based in Nagpur, India.
www.zimlab.in556
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: ZIMLAB.NS
View MorePerformance Overview: ZIMLAB.NS
Trailing total returns as of 4/25/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ZIMLAB.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ZIMLAB.NS
View MoreValuation Measures
Market Cap
4.28B
Enterprise Value
5.23B
Trailing P/E
27.96
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.14
Price/Book (mrq)
1.77
Enterprise Value/Revenue
1.39
Enterprise Value/EBITDA
10.59
Financial Highlights
Profitability and Income Statement
Profit Margin
3.96%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
3.88B
Net Income Avi to Common (ttm)
153.66M
Diluted EPS (ttm)
3.15
Balance Sheet and Cash Flow
Total Cash (mrq)
58.15M
Total Debt/Equity (mrq)
41.48%
Levered Free Cash Flow (ttm)
--